HAMİT ALİ, NAZLİ BEGUM OZTURK, N EMRE HERDAN, HARRY LUU, CEM SİMSEK, RUMEYZA KAZANCİOGLU, AHMET GURAKAR
Hepatology Forum - 2024;5(4):207-210
Simultaneous liver-kidney transplantation (SLK) is a feasible option for patients with end-stage liver disease and concomitant renal dysfunction or end-stage renal disease. SLK has gained significant attention primarily due to multiple alterations in the allocation criteria over the past two decades. This review aims to summarize the most recent updates and outcomes of the SLK allocation policy, comparing SLK outcomes with those of liver transplantation alone and exploring the implications of donation after cardiac death in SLK procedures.
